How do GLP-1 injections enhance your weight loss results
Wegovy is approved to reduce the risk of cardiovascular disease, and Zepbound is approved to treat obstructive sleep apnea
Earlier this year, the pharma company confirmed that its GLP-1 focused drug, currently just called PF-08653944, is performing very well in Phase 2b trials
Both GLP-1 receptor agonists and SGLT2 inhibitors act directly on the proximal tubule to block sodium hyper-reabsorption [97, 98]
TPE has been used as part of treatment plans for Alzheimers disease, inflammatory conditions, chronic viral infections, kidney issues, and more by reducing the protein and harmful components in the body
The GIP component enhances insulin secretion and may improve fat metabolism